Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Fatma Soliman Elsayed Ebeid"'
Autor:
Manal Hamdy El-Sayed, Salwa Mostafa Abd El Kader, Fatma Soliman Elsayed Ebeid, Fatma Mohamed El-Shorbagy, Iman Ahmed Ragab
Publikováno v:
Egyptian Liver Journal, Vol 14, Iss 1, Pp 1-8 (2024)
Abstract Background Hepatic manifestations of hemophagocytic lymphohistiocytosis (HLH), an underrecognized primary presentation in pediatric age group, mandate high levels of suspicion for early diagnosis. Aim This is to study the frequencies of clin
Externí odkaz:
https://doaj.org/article/35a356de46a9450c901cf56c0236c6d2
Autor:
Basant Mohamed Raief Mosaad, Ahmed Samir Ibrahim, Mohamed G. Mansour, Mohsen Saleh ElAlfy, Fatma Soliman Elsayed Ebeid, Emad H. Abdeldayem
Publikováno v:
Insights into Imaging, Vol 13, Iss 1, Pp 1-10 (2022)
Abstract Objectives Pancreatic reserve could be preserved by early assessment of pancreatic iron overload among transfusion-dependent sickle cell disease (SCD) patients. This study aimed to measure pancreatic iron load and correlate its value with pa
Externí odkaz:
https://doaj.org/article/965cdf2a1ff741df97420aa046c15724
Autor:
Mohsen Saleh ElAlfy, Azaa Abdel Gawad Tantawy, Badr Eldin Mostafa Badr Eldin, Mohamed Amin Mekawy, Yasmeen Abd elAziz Mohammad, Fatma Soliman Elsayed Ebeid
Publikováno v:
International Archives of Otorhinolaryngology, Vol 26, Iss 02, Pp e183-e190 (2022)
Introduction Epistaxis is a common presentation among children. Objective To investigate the suitability of a simple tool of assessment for patients with epistaxis that could guide in subgrouping those with possible bleeding tendencies who may need f
Externí odkaz:
https://doaj.org/article/142fdc9e2b154979bf996fa783d225de
Autor:
Fatma Soliman Elsayed Ebeid
Publikováno v:
Perspectives in Clinical Research, Vol 11, Iss 3, Pp 106-110 (2020)
Background: The ongoing coronavirus disease 2019 (COVID-19) pandemic is extensively impacting new and ongoing clinical trials of various medical products irrespective of indication. It has the potential to adverse effect not only in terms of recruitm
Externí odkaz:
https://doaj.org/article/f01d23267b3c4c85affd6131dc2f47f1
Autor:
Fatma Soliman Elsayed Ebeid
Publikováno v:
Transfusion and Apheresis Science. :103719
Autor:
Azza Abdel Gawad, Tantawy, Mourad Alfy Ramzy, Tadros, Amira Abdel Moneam, Adly, Eman Abdel Rahman, Ismail, Fatma A, Ibrahim, Nanis Mohammed, Salah Eldin, Mahitab Morsy, Hussein, Mervat Abdalhameed, Alfeky, Sarah Mohammed, Ibrahim, Marwa Adel, Hashem, Fatma Soliman Elsayed, Ebeid
Publikováno v:
Cytokine. 161:156048
Endothelin-1 (ET-1), a potent endogenous vasoconstrictor, stimulates production of reactive oxygen species. Endothelial monocyte-activating polypeptide-II (EMAP-II) is a multifunctional polypeptide.To assess ET-1 gene polymorphism (G8002A) in pediatr
Autor:
Fatima Zahrra Abdelkarim Saed, Mahmoud Adel Kenny, Fatma Soliman Elsayed Ebeid, Mohsen Saleh Elalfy
Publikováno v:
QJM: An International Journal of Medicine. 114
Background Transfusion is critical in the management of sickle cell disease (SCD) complications. The resultant alloimmunization to RBC group antigens is a major complication of allogeneic blood transfusion and generally presents significant challenge
Brain Iron Content in Egyptian Patients with Sickle Cell Disease: Impact on Neurocognitive Functions
Autor:
Ghada M Samir, Hanaa Midhat Abdel Gader Hussein, Hend A. Mohammed, Mohsen Saleh Elalfy, Fatma Soliman Elsayed Ebeid, Ahmed Smair
Publikováno v:
Blood. 136:37-37
Background:Children with sickle cell disease (SCD) are at a high risk for neurocognitive impairment which may be due to iron overload in brain tissue or hemoglobin polymerization and endothelial dysfunction.Primary objectivewas measuring brain iron c
Autor:
Mohsen Saleh, ElAlfy, Amira Abdel Moneam, Adly, Fatma Soliman ElSayed, Ebeid, Deena Samir, Eissa, Eman Abdel Rahman, Ismail, Yasser Hassan, Mohammed, Manar Elsayed, Ahmed, Aya Sayed, Saad
Publikováno v:
Immunologic research. 66(4)
Sickle cell disease (SCD) is associated with alterations in immune phenotypes. CD4
Autor:
M. A. Badr, Theresa Chan, Julie Kanter, Janet L. Kwiatkowski, Baba Inusa, Alshehri Abdulrahman, Suzan Williams, Michael Spino, Mohsen Saleh Elalfy, Fernando Tricta, Anna Rozova, David M. Lee, Mohamed Bejaoui, Anne Stilman, Fatma Soliman Elsayed Ebeid, Amal El-Beshlawy, Dian Shaw, Yurdanur Kilinç, Caroline Fradette, Yu-Chung Tsang, Jodie Sinclair, Mona Hamdy, Noemi Toiber Temin, Mônica Pinheiro de Almeida Veríssimo
Publikováno v:
Blood. 134:618-618
Background: Patients with sickle cell disease (SCD) or other rare anemias whose care includes chronic blood transfusions must receive iron chelation to prevent the morbidity of iron overload. Currently, only deferoxamine (DFO) and deferasirox (DFX) a